{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T04:18:25Z","timestamp":1778991505707,"version":"3.51.4"},"reference-count":60,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:00:00Z","timestamp":1540425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["31003A_140868"],"award-info":[{"award-number":["31003A_140868"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>(1) Background: In an adult skeleton, bone is constantly renewed in a cycle of bone resorption, followed by bone formation. This coupling process, called bone remodeling, adjusts the quality and quantity of bone to the local needs. It is generally accepted that osteoporosis develops when bone resorption surpasses bone formation. Osteoclasts and osteoblasts, bone resorbing and bone forming cells respectively, are the major target in osteoporosis treatment. Inside bone and forming a complex network, the third and most abundant cells, the osteocytes, have long remained a mystery. Osteocytes are responsible for mechano-sensation and -transduction. Increased expression of the osteocyte-derived bone inhibitor sclerostin has been linked to estrogen deficiency-induced osteoporosis and is therefore a promising target for osteoporosis management. (2) Methods: Recently we showed in vitro and in vivo that NMP (N-Methyl-2-pyrrolidone) is a bioactive drug enhancing the BMP-2 (Bone Morphogenetic Protein 2) induced effect on bone formation while blocking bone resorption. Here we tested the effect of NMP on the expression of osteocyte-derived sclerostin. (3) Results: We found that NMP significantly decreased sclerostin mRNA and protein levels. In an animal model of osteoporosis, NMP prevented the estrogen deficiency-induced increased expression of sclerostin. (4) Conclusions: These results support the potential of NMP as a novel therapeutic compound for osteoporosis management, since it preserves bone by a direct interference with osteoblasts and osteoclasts and an indirect one via a decrease in sclerostin expression by osteocytes.<\/jats:p>","DOI":"10.3390\/ijms19113332","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T03:16:16Z","timestamp":1540523776000},"page":"3332","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Bromodomain Inhibitor N-Methyl pyrrolidone Prevents Osteoporosis and BMP-Triggered Sclerostin Expression in Osteocytes"],"prefix":"10.3390","volume":"19","author":[{"given":"Barbara","family":"Siegenthaler","sequence":"first","affiliation":[{"name":"Center of Dental Medicine, Oral Biotechnology &amp; Bioengineering, University of Zurich, Plattenstrasse 11, 8032 Z\u00fcrich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chafik","family":"Ghayor","sequence":"additional","affiliation":[{"name":"Center of Dental Medicine, Oral Biotechnology &amp; Bioengineering, University of Zurich, Plattenstrasse 11, 8032 Z\u00fcrich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bebeka","family":"Gjoksi-Cosandey","sequence":"additional","affiliation":[{"name":"Center of Dental Medicine, Oral Biotechnology &amp; Bioengineering, University of Zurich, Plattenstrasse 11, 8032 Z\u00fcrich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisarat","family":"Ruangsawasdi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Dentistry, Mahidol University, Bangkok 10400, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1670-2296","authenticated-orcid":false,"given":"Franz E.","family":"Weber","sequence":"additional","affiliation":[{"name":"Center of Dental Medicine, Oral Biotechnology &amp; Bioengineering, University of Zurich, Plattenstrasse 11, 8032 Z\u00fcrich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2018,10,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"(2001). NIH, Osteoporosis prevention, diagnosis, and therapy. JAMA, 285, 785\u2013795.","DOI":"10.1001\/jama.285.6.785"},{"key":"ref_2","unstructured":"Foundation, I.O. (2018, August 26). What Is Osteoporosis. Available online: https:\/\/www.iofbonehealth.org\/epidemiology."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.bone.2005.11.024","article-title":"Osteoporosis: A still increasing prevalence","volume":"38","author":"Reginster","year":"2006","journal-title":"Bone"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1358\/dot.1999.35.3.533847","article-title":"Monitoring antiosteoporotic treatment of postmenopausal women using biochemical markers of bone turnover","volume":"35","author":"Kress","year":"1999","journal-title":"Drugs Today"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.tem.2004.01.006","article-title":"Parathyroid hormone: A double-edged sword for bone metabolism","volume":"15","author":"Qin","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1080\/13543784.2017.1371136","article-title":"Investigational anabolic agents for the treatment of osteoporosis: An update on recent developments","volume":"26","author":"Dede","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tice.2016.03.009","article-title":"Strontium ranelate increases osteoblast activity","volume":"48","author":"Almeida","year":"2016","journal-title":"Tissue Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s00198-015-3109-y","article-title":"The position of strontium ranelate in today\u2019s management of osteoporosis","volume":"26","author":"Reginster","year":"2015","journal-title":"Osteoporos. Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"24458","DOI":"10.1074\/jbc.M111.223297","article-title":"Inhibition of osteoclast differentiation and bone resorption by N-methyl pyrrolidone","volume":"286","author":"Ghayor","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1089\/ten.tea.2009.0009","article-title":"N-methyl pyrrolidone as a potent bone morphogenetic protein enhancer for bone tissue regeneration","volume":"15","author":"Miguel","year":"2009","journal-title":"Tissue Eng. Part A"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bone.2015.05.004","article-title":"The epigenetically active small chemical N-methyl pyrrolidone (NMP) prevents estrogen depletion induced osteoporosis","volume":"78","author":"Gjoksi","year":"2015","journal-title":"Bone"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Gong, F., Chiu, L.Y., and Miller, K.M. (2016). Acetylation reader proteins: Linking acetylation signaling to genome maintenance and cancer. PLoS Genet., 12.","DOI":"10.1371\/journal.pgen.1006272"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1189\/jlb.2RI0616-250R","article-title":"Bromodomain 4: A cellular Swiss army knife","volume":"100","author":"Devaiah","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/cmdc.201300259","article-title":"Naphthyridines as novel BET family bromodomain inhibitors","volume":"9","author":"Mirguet","year":"2014","journal-title":"ChemMedChem"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1039\/c1mb05099k","article-title":"Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery","volume":"7","author":"Philpott","year":"2011","journal-title":"Mol. Biosyst."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.celrep.2014.04.008","article-title":"The drug vehicle and solvent N-methyl pyrrolidone is an immunomodulator and antimyeloma compound","volume":"7","author":"Shortt","year":"2014","journal-title":"Cell Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.320","article-title":"The amazing osteocyte","volume":"26","author":"Bonewald","year":"2011","journal-title":"J. Bone Min. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/dvdy.20603","article-title":"Buried alive: How osteoblasts become osteocytes","volume":"235","author":"Hall","year":"2006","journal-title":"Dev. Dyn."},{"key":"ref_19","first-page":"115","article-title":"Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocr. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.22203\/eCM.v031a21","article-title":"Osteocyte differentiation and the formation of an interconnected cellular network in vitro","volume":"31","author":"Mullen","year":"2016","journal-title":"Eur. Cells Mater."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1138\/20090363","article-title":"Regulation of bone resorption and mineral homeostasis by osteocytes","volume":"6","author":"Pajevic","year":"2009","journal-title":"IBMS BoneKEy"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s004290050145","article-title":"Stromal cell structure and relationships in perimedullary spaces of chick embryo shaft bones","volume":"197","author":"Palazzini","year":"1998","journal-title":"Anat. Embryol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1357-2725(03)00241-3","article-title":"The osteocyte","volume":"36","author":"Adamson","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jcb.10109","article-title":"Osteocytes inhibit osteoclastic bone resorption through transforming growth factor-\u03b2: Enhancement by estrogen","volume":"85","author":"Heino","year":"2002","journal-title":"J. Cell. Biochem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1359\/jbmr.2002.17.11.2068","article-title":"MLO-Y4 osteocyte-like cells support osteoclast formation and activation","volume":"17","author":"Zhao","year":"2002","journal-title":"J. Bone Min. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"35939","DOI":"10.1074\/jbc.M109.060335","article-title":"The matricellular protein periostin is required for sost inhibition and the anabolic response to mechanical loading and physical activity","volume":"284","author":"Bonnet","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Grimston, S.K., Watkins, M.P., Brodt, M.D., Silva, M.J., and Civitelli, R. (2012). Enhanced periosteal and endocortical responses to axial tibial compression loading in conditional connexin43 deficient mice. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0044222"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bone.2015.03.019","article-title":"In vivo mechanical loading rapidly activates beta-catenin signaling in osteocytes through a prostaglandin mediated mechanism","volume":"76","author":"Kamel","year":"2015","journal-title":"Bone"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bone.2009.10.021","article-title":"Loading-related regulation of gene expression in bone in the contexts of estrogen deficiency, lack of estrogen receptor alpha and disuse","volume":"46","author":"Zaman","year":"2010","journal-title":"Bone"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1096\/fj.05-4221fje","article-title":"Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation","volume":"19","author":"Poole","year":"2005","journal-title":"FASEB J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1074\/jbc.M705092200","article-title":"Mechanical stimulation of bone in vivo reduces osteocyte expression of SOST\/sclerostin","volume":"283","author":"Robling","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1172\/JCI106019","article-title":"Bone matrix turnover and balance in vitro. II. The effects of aging","volume":"48","author":"Flanagan","year":"1969","journal-title":"J. Clin. Investig."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1210\/jc.2009-2283","article-title":"Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women","volume":"95","author":"Mirza","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jbmr.128","article-title":"Regulation of circulating sclerostin levels by sex steroids in women and in men","volume":"26","author":"Modder","year":"2011","journal-title":"J. Bone Min. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bone.2011.04.015","article-title":"Effects of estrogen on osteoprogenitor cells and cytokines\/bone-regulatory factors in postmenopausal women","volume":"49","author":"Modder","year":"2011","journal-title":"Bone"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"160120","DOI":"10.1098\/rsob.160120","article-title":"The sclerostin-neutralizing antibody AbD09097 recognizes an epitope adjacent to sclerostin\u2019s binding site for the Wnt co-receptor LRP6","volume":"6","author":"Boschert","year":"2016","journal-title":"Open Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1517\/14712598.2014.895808","article-title":"Update on romosozumab: A humanized monoclonal antibody to sclerostin","volume":"14","author":"Costa","year":"2014","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jbmr.2351","article-title":"A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density","volume":"30","author":"Recker","year":"2015","journal-title":"J. Bone Min. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1089\/ten.tea.2014.0585","article-title":"Estrogen modulates bone morphogenetic protein-induced sclerostin expression through the Wnt signaling pathway","volume":"21","author":"Kim","year":"2015","journal-title":"Tissue Eng. Part A"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.bone.2004.04.019","article-title":"Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblasts","volume":"35","author":"Sutherland","year":"2004","journal-title":"Bone"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1002\/jbmr.465","article-title":"Cell line IDG-SW3 replicates osteoblast-to-late-osteocyte differentiation in vitro and accelerates bone formation in vivo","volume":"26","author":"Woo","year":"2011","journal-title":"J. Bone Min. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrd4286","article-title":"Targeting bromodomains: Epigenetic readers of lysine acetylation","volume":"13","author":"Filippakopoulos","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bone.2016.10.008","article-title":"Sclerostin\u2019s role in bone\u2019s adaptive response to mechanical loading","volume":"96","author":"Galea","year":"2016","journal-title":"Bone"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1158\/1078-0432.CCR-13-2281","article-title":"BET bromodomain inhibition of MYC-amplified medulloblastoma","volume":"20","author":"Bandopadhayay","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/leu.2016.260","article-title":"BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells","volume":"31","author":"Saenz","year":"2016","journal-title":"Leukemia"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.3892\/or.2016.5037","article-title":"JQ1, a small molecule inhibitor of BRD4, suppresses cell growth and invasion in oral squamous cell carcinoma","volume":"36","author":"Wang","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/jbmr.1491","article-title":"DNA methylation contributes to the regulation of sclerostin expression in human osteocytes","volume":"27","author":"Sanudo","year":"2012","journal-title":"J. Bone Min. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1359\/jbmr.1998.13.7.1124","article-title":"Response of biochemical markers of bone turnover to hormone replacement therapy: Impact of biological variability","volume":"13","author":"Hannon","year":"1998","journal-title":"J. Bone Min. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1002\/jbmr.2278","article-title":"Mechanical load increases in bone formation via a sclerostin-independent pathway","volume":"29","author":"Morse","year":"2014","journal-title":"J. Bone Min. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.cmet.2007.05.001","article-title":"Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction","volume":"5","author":"Tatsumi","year":"2007","journal-title":"Cell Metab."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"13849","DOI":"10.1074\/jbc.M306249200","article-title":"Cbfa1\/RUNX2 directs specific expression of the sclerosteosis gene (SOST)","volume":"279","author":"Sevetson","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1101\/gr.3437105","article-title":"Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease","volume":"15","author":"Loots","year":"2005","journal-title":"Genome Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11914-014-0188-1","article-title":"Developments in sclerostin biology: Regulation of gene expression, mechanisms of action, and physiological functions","volume":"12","author":"Weivoda","year":"2014","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1749-6632.2009.05246.x","article-title":"Dynamics of the transition from osteoblast to osteocyte","volume":"1192","author":"Dallas","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"24995","DOI":"10.1074\/jbc.M114.564997","article-title":"Class I and IIa histone deacetylases have opposite effects on sclerostin gene regulation","volume":"289","author":"Baertschi","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0960-9822(06)00296-X","article-title":"Acetylation of general transcription factors by histone acetyltransferases","volume":"7","author":"Imhof","year":"1997","journal-title":"Curr. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/jbmr.1492","article-title":"MEF2C deletion in osteocytes results in increased bone mass","volume":"27","author":"Kramer","year":"2012","journal-title":"J. Bone Min. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1359\/jbmr.070804","article-title":"Control of the SOST bone enhancer by PTH using MEF2 transcription factors","volume":"22","author":"Leupin","year":"2007","journal-title":"J. Bone Min. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/jbmr.2381","article-title":"HDAC5 controls MEF2C-driven sclerostin expression in osteocytes","volume":"30","author":"Wein","year":"2015","journal-title":"J. Bone Min. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/11\/3332\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:26:16Z","timestamp":1760196376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/11\/3332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,25]]},"references-count":60,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11]]}},"alternative-id":["ijms19113332"],"URL":"https:\/\/doi.org\/10.3390\/ijms19113332","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,25]]}}}